The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

Critics argue that NIH directors should have term limits. Others say leadership continuity matters. Who's right?

As the risk of measles mounts, health care workers face an unusual challenge: Many don't know what it looks like.

The MAHA movement’s embrace of unorthodox therapies has deep roots in U.S. history, says law professor Lewis Grossman.

A skin condition tied to delusions is posing a riddle for doctors: What to do when a diagnosis causes offense?

Artificial intelligence could reshape both the creation and evaluation of research. But experts warn of risks.

No wonder the European Marine Energy Center, one of the world’s leading agencies for developing and testing wave and tidal power technologies, chose to set up shop here; the nonprofit agency hosts ...

It’s possible that traditional discipline could have prevented the shooting. Henderson had a history of violence and threats against family, students, and teachers. The teenager had recently been ...

Tracking science's inexorable and often unregulated pursuit of engineered cognition.

In the late 1980s, at a federal research facility in Pensacola, Florida, Tamar Barkay used mud in a way that proved revolutionary in a manner she could never have imagined at the time: a crude version ...

Understanding how a healthy brain works can provide insight into how it fails, too. Scientists hope that studying organoids derived from humans with neurodevelopmental disorders — particularly ...

HHS states it was cleaning up "dated content." But advocates for people with autism say the warnings are still needed.